Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,648 | -40,971 | -15,149 | -4,982 | 180,356 |
| Depreciation Amortization | 10,768 | 7,564 | 4,580 | 2,053 | 7,192 |
| Accounts receivable | 17,360 | 23,220 | 8,819 | 5,799 | 26,314 |
| Accounts payable and accrued liabilities | -1,129 | 2,012 | -867 | 4,712 | 315 |
| Other Working Capital | 43,148 | 51,358 | 39,130 | 41,369 | 10,301 |
| Other Operating Activity | -2,500 | -14,969 | -1,238 | -7,254 | -10,753 |
| Operating Cash Flow | $8,999 | $28,214 | $35,275 | $41,697 | $213,725 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,484 | 20,347 | -5,935 | -44,817 | -248,857 |
| PPE Investments | -15,491 | -14,613 | -11,863 | -8,203 | -8,699 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -4,500 |
| Purchase Of Investment | -400 | -400 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -6,664 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -6,664 |
| Investing Cash Flow | $-7,407 | $5,334 | $-17,798 | $-53,020 | $-268,720 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,729 |
| Common Stock Issued | 2,153 | 2,104 | 1,605 | 735 | 5,546 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -258 |
| Financing Cash Flow | $2,153 | $2,104 | $1,605 | $735 | $3,559 |
| Beginning Cash Position | 49,245 | 49,245 | 49,245 | 49,245 | 100,681 |
| End Cash Position | 52,990 | 84,897 | 68,327 | 38,657 | 49,245 |
| Net Cash Flow | $3,745 | $35,652 | $19,082 | $-10,588 | $-51,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,999 | 28,214 | 35,275 | 41,697 | 213,725 |
| Capital Expenditure | -15,491 | -14,613 | -11,863 | -8,203 | -8,699 |
| Free Cash Flow | -6,492 | 13,601 | 23,412 | 33,494 | 205,026 |